Common blood pressure medicine blocks molecule that can trigger the disease
A drug commonly used to control high blood pressure may also help prevent the onset of Type 1 diabetes in up to 60 percent of those at risk for the disease, according to researchers at the University of Colorado Anschutz Medical Campus and the University of Florida (UF) in Gainesville.
The study was published online this week in the Journal of Clinical Investigation.
“This is the first personalized treatment for Type 1 diabetes prevention,” said Aaron Michels, MD, a researcher at the Barbara Davis Center for Childhood Diabetes and associate professor of medicine at CU Anschutz. “We made this discovery using a supercomputer, on the lab bench, in mice and in humans.”
The drug, methyldopa, has been used for over 50 years to treat high blood pressure in pregnant women and children. It is on the World Health Organization’s list of essential drugs.
But like many drugs used for one condition, Michels and his colleagues found it useful for something totally unrelated.
Some 60 percent of people at risk of getting Type 1 diabetes possess the DQ8 molecule which significantly increases the chance of getting the disease. The researchers believed that if they could block specifically the DQ8 molecule they could also block the onset of the disease.
“All drugs have off-target effects. If you take too much acetaminophen you can hurt your liver,” Michels said. “We took every FDA-approved small molecule drug and analyzed HLA-DQ8 binding through a supercomputer. We searched a thousand orientations for each drug to identify those that would fit within the DQ8 molecule binding groove.”
After running thousands of drugs through the supercomputer, they found that methyldopa not only blocked DQ8, but it didn’t harm the immune function of other cells like many immunosuppressant drugs do.
The research spanned 10 years and its efficacy was shown in mice and in 20 Type 1 diabetes patients who took part in a clinical trial at the Barbara Davis Center at the University of Colorado School of Medicine.
“We can now predict with almost 100 percent accuracy who is likely to get Type 1 diabetes,” Michels said. “The goal with this drug is to delay or prevent the onset of the disease among those at risk.”
The drug is taken orally, three times a day.
Implications for treatment
Michels and UF Health researcher David Ostrov, PhD, hope this same approach of blocking specific molecules can be used in other diseases.
“This study has significant implications for treatment of diabetes and also other autoimmune diseases,” said Ostrov, associate professor of pathology, immunology and laboratory medicine in the UF College of Medicine and a member of the UF Health Cancer Center, Genetics Institute and Center for NeuroGenetics. “This study suggests that the same approach may be adapted to prevent autoimmune diseases such as rheumatoid arthritis, coeliac disease, multiple sclerosis, systemic lupus erythematosus and others.”
The next step will be a larger clinical trial sponsored by the National Institutes of Health in spring.
“With this drug, we can potentially prevent up to 60 percent of Type 1 diabetes in those at risk for the disease,” Michels said. “This is very significant development.”
The Latest on: Type 1 diabetes
New study links walnuts to lower risk of Type 2 diabetes
on July 11, 2018 at 2:51 pm
Los Angeles (UCLA), the average intake among walnut consumers was approximately 1.5 tablespoons per day. Doubling walnut consumption (eating 3 tablespoons) was associated with a 47% lower prevalence o... […]
Diabetes Research Institute Launches New Clinical Trial to Explore Effects of Omega-3 Fatty Acids and Vitamin D in Type 1 Diabetes
on July 11, 2018 at 12:35 pm
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here. MIAMI, July 11, 2018 /PRNewswire-USNewswire/ -- Scientists from the Diabetes Research Institute (DRI) at the Unive... […]
New type 1 Diabetes clinical trial explores effects of Omega-3 and Vitamin D
on July 11, 2018 at 10:57 am
Scientists from the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine today announced the launch of a new clinical trial that will assess the impact of high-dose o... […]
Insurance gaps can be costly for type 1 diabetes patients, study says
on July 11, 2018 at 6:54 am
WEDNESDAY, July 11, 2018 -- Gaps in private insurance coverage are common among American adults with type 1 diabetes, raising their risk for health crises, a new study finds. "Type 1 diabetes requires ... […]
For people with diabetes, air travel can present a host of challenges
on July 11, 2018 at 6:40 am
He also has Type 1 diabetes. On a recent overnight flight to Europe, where he planned to attend a medical conference, he made a troubling discovery. “I opened my carrying case for my insulin and suppl... […]
Stopping type 1 diabetes from birth
on July 10, 2018 at 5:11 pm
Experts believe they may have found a way to prevent high risk babies from developing type 1 diabetes. The idea is to train infants' immune systems by giving them powdered insulin to offer life-long p... […]
Type 1 Diabetes in Mothers Linked to Higher Risk of Autism in Children
on July 10, 2018 at 2:48 pm
Researchers say women with type 1 diabetes have a higher risk of having offspring with autism. They aren’t sure why, but glucose levels may be a factor. That’s the conclusion of a recent study from Ka... […]
New technology for early detection of type 1 diabetes
on July 10, 2018 at 7:47 am
The proof-of-concept sensor for the early detection of type 1 diabetes. Coated with special nanoparticles, the sensor can detect biomarkers in the blood that predict the health of insulin-producing ce... […]
Verapamil May Improve Beta-Cell Function in Type 1 Diabetes
on July 10, 2018 at 7:19 am
The old antihypertensive drug verapamil may help reduce insulin requirements and hypoglycemic episodes in adults with type 1 diabetes, new research suggests. Results from the study were published onli... […]
Researchers may have found new a way to help treat type 1 diabetes – and it's with a drug that has been on the market for over 30 years
on July 10, 2018 at 4:16 am
A new study published in Nature Medicine found that a drug used to treat high blood pressure could help patients with type 1 diabetes stabilize blood sugar levels. Verapamil, a calcium channel blocker ... […]
via Google News and Bing News